The Claim

In adults with abdominal obesity and low-grade inflammation, 10 weeks of daily 2.7-gram DHA supplementation reduces C-reactive protein (CRP) by 7.9%, while daily 2.7-gram EPA supplementation reduces CRP by 1.8%, with no statistically significant difference between the two effects.

Source: A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
84score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
1 study reviewed
In plain English

In adults with abdominal obesity and low-grade inflammation, 10 weeks of daily 2.7-gram DHA supplementation lowers C-reactive protein levels by 7.9%, while the same dose of EPA lowers it by 1.8%, with no statistically significant difference between the two.

See the scientific wording

In adults with abdominal obesity and low-grade inflammation, 10 weeks of daily 2.7-gram DHA supplementation reduces C-reactive protein (CRP) by 7.9%, while EPA reduces it by only 1.8%, though this difference is not statistically significant, suggesting DHA may have a modestly stronger anti-inflammatory effect on CRP than EPA.

Why this might work

DHA gets absorbed into fat and immune cells, where it is turned into molecules that stop inflammation. These molecules block a key inflammation switch in the liver, which reduces the production of CRP. At the same time, DHA increases a fat-derived hormone that further calms liver inflammation and clears out leftover debris.

Supported mechanismbased on 1 study

What the research says

1 study
  1. Study: A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.

    In people with belly fat and inflammation, taking DHA for 10 weeks lowered a key inflammation marker (CRP) more than taking the same amount of EPA — but the difference wasn't big enough to say for sure it wasn't just luck. Still, DHA did better on other inflammation and heart health measures, so it might be more effective.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.